Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105


Micro-RNA149 confers taxane resistance to malignant mesothelioma cells via regulation of P-glycoprotein expression.

Kenworthy R, Bosco DB, DeLigio JT, Zorio DAR.

Cancer Biol Ther. 2018 Mar 4;19(3):181-187. doi: 10.1080/15384047.2017.1415677. Epub 2018 Jan 15.


Current and Prospective Protein Biomarkers of Lung Cancer.

Zamay TN, Zamay GS, Kolovskaya OS, Zukov RA, Petrova MM, Gargaun A, Berezovski MV, Kichkailo AS.

Cancers (Basel). 2017 Nov 13;9(11). pii: E155. doi: 10.3390/cancers9110155. Review.


Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis.

Hu Y, Wang L, Gu J, Qu K, Wang Y.

Oncotarget. 2017 Aug 12;8(43):74554-74566. doi: 10.18632/oncotarget.20218. eCollection 2017 Sep 26.


Protein-coding genes, long non-coding RNAs combined with microRNAs as a novel clinical multi-dimension transcriptome signature to predict prognosis in ovarian cancer.

Meng X, Jin-Cheng G, Jue Z, Quan-Fu M, Bin Y, Xu-Feng W.

Oncotarget. 2017 Aug 24;8(42):72847-72859. doi: 10.18632/oncotarget.20457. eCollection 2017 Sep 22.


Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.

Wang K, Chen M, Wu W.

World J Surg Oncol. 2017 Sep 19;15(1):175. doi: 10.1186/s12957-017-1244-y.


The significance of microRNA-148/152 family as a prognostic factor in multiple human malignancies: a meta-analysis.

Miao C, Zhang J, Zhao K, Liang C, Xu A, Zhu J, Wang Y, Hua Y, Tian Y, Liu S, Zhang C, Qin C, Wang Z.

Oncotarget. 2017 Jun 27;8(26):43344-43355. doi: 10.18632/oncotarget.17949.


MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.

Hu B, Sun M, Liu J, Hong G, Lin Q.

Oncol Lett. 2017 May;13(5):3823-3830. doi: 10.3892/ol.2017.5907. Epub 2017 Mar 24.


An approach to forecast human cancer by profiling microRNA expressions from NGS data.

Salim A, Amjesh R, Chandra SS.

BMC Cancer. 2017 Jan 25;17(1):77. doi: 10.1186/s12885-016-3042-2.


MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology.

Shah P, Cho SK, Thulstrup PW, Bjerrum MJ, Lee PH, Kang JH, Bhang YJ, Yang SW.

J Mov Disord. 2017 Jan;10(1):18-28. doi: 10.14802/jmd.16037. Epub 2017 Jan 18. Review.


Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features.

Sato H, Shien K, Tomida S, Okayasu K, Suzawa K, Hashida S, Torigoe H, Watanabe M, Yamamoto H, Soh J, Asano H, Tsukuda K, Miyoshi S, Toyooka S.

Sci Rep. 2017 Jan 13;7:40847. doi: 10.1038/srep40847.


Non-Coding RNAs in Lung Cancer: Contribution of Bioinformatics Analysis to the Development of Non-Invasive Diagnostic Tools.

Kunz M, Wolf B, Schulze H, Atlan D, Walles T, Walles H, Dandekar T.

Genes (Basel). 2016 Dec 26;8(1). pii: E8. doi: 10.3390/genes8010008. Review.


Lung Cancer Gene Signatures and Clinical Perspectives.

Kuner R.

Microarrays (Basel). 2013 Dec 13;2(4):318-39. doi: 10.3390/microarrays2040318. Review.


miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli.

Shu Z, Chen L, Ding D.

World J Surg Oncol. 2016 Sep 6;14(1):239. doi: 10.1186/s12957-016-0984-4.


Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.

Su TJ, Ku WH, Chen HY, Hsu YC, Hong QS, Chang GC, Yu SL, Chen JJ.

Am J Cancer Res. 2016 Jun 1;6(6):1317-30. eCollection 2016.


Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers.

Ning S, Gao Y, Wang P, Li X, Zhi H, Zhang Y, Liu Y, Zhang J, Guo M, Han D, Li X.

Oncotarget. 2016 Jul 19;7(29):45937-45947. doi: 10.18632/oncotarget.10004.


miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor.

Qin Q, Wei F, Zhang J, Wang X, Li B.

J Cell Mol Med. 2016 Oct;20(10):1974-83. doi: 10.1111/jcmm.12889. Epub 2016 May 31.


Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.

He Z, Xia Y, Liu B, Qi X, Li Z, Wang J, Chen L, Chen Y.

J Thorac Dis. 2016 May;8(5):894-900. doi: 10.21037/jtd.2016.03.51.


Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.

Cinegaglia NC, Andrade SC, Tokar T, Pinheiro M, Severino FE, Oliveira RA, Hasimoto EN, Cataneo DC, Cataneo AJ, Defaveri J, Souza CP, Marques MM, Carvalho RF, Coutinho LL, Gross JL, Rogatto SR, Lam WL, Jurisica I, Reis PP.

Oncotarget. 2016 May 17;7(20):28920-34. doi: 10.18632/oncotarget.8713.


MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.

Chen L, Kong G, Zhang C, Dong H, Yang C, Song G, Guo C, Wang L, Yu H.

Oncotarget. 2016 Apr 12;7(15):20041-53. doi: 10.18632/oncotarget.7884.

Supplemental Content

Support Center